Skip to main content

Advertisement

Log in

Diffuse alveolar hemorrhage following intravenous thrombolytic treatment in acute ischemic stroke: a case series

  • Brief Communication
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Diffuse alveolar hemorrhage (DAH) following fibrinolytic therapy is a rare but a life-threatening complication. In acute ischemic stroke (AIS), DAH as a complication was not reported following intravenous thrombolytic therapy (ITT). The demographic, clinical, radiologic, and prognostic data of 4 patients with AIS who developed DAH after ITT are presented in this case series, along with a literature review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Nasser M, Cottin V (2018) Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med 39:482–493

    Article  Google Scholar 

  2. Newsome BR, Morales JE (2011) Diffuse alveolar hemorrhage. South Med J 104:269–274

    Article  Google Scholar 

  3. Schwarz MI, Fontenot AP (2004) Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 25:133–140

    Article  Google Scholar 

  4. Heslet L, Nielsen JD, Nepper-Christensen S (2012) Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm. Biologics 6:37–46

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Rabe C, Appenrodt B, Hoff C, Ewig S, Klehr HU, Sauerbruch T, Nickenig G, Tasci S (2010) Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care 25:230–235

    Article  Google Scholar 

  6. Yigla M, Sprecher E, Azzam Z, Guralnik L, Kapeliovich M, Krivoy N (2000) Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction. Respiration 67:445–448

    Article  CAS  Google Scholar 

  7. Narayanan S, Thulaseedharan NK, Subramaniam G, Panarkandy G, Arathi N (2017) Pulmonary alveolar hemorrhage following thrombolytic therapy. Int Med Case Rep J 10:123–125

    Article  Google Scholar 

  8. Nathan PE, Torres AV, Smith AJ, Gagliardi AJ, Rapeport KB (1992) Spontaneous pulmonary hemorrhage following coronary thrombolysis. Chest 101:1150–1152

    Article  CAS  Google Scholar 

  9. Gopalakrishnan D, Tioran T, Emanuel C, Clark VL (1997) Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction. Clin Cardiol 20:298–300

    Article  CAS  Google Scholar 

  10. Iskandar SB, Kasasbeh ES, Mechleb BK, Garcia I, Jackson A, Fahrig S, Albalbissi K, Henry PD (2006) Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors. J Interv Cardiol 19:356–363

    Article  Google Scholar 

  11. Kalra S, Bell MR, Rihal CS (2001) Alveolar hemorrhage as a complication of treatment with abciximab. Chest 120:126–131

    Article  CAS  Google Scholar 

  12. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galie N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402–1411

    Article  CAS  Google Scholar 

  13. Levine MN, Goldhaber SZ, Califf RM, Gore JM, Hirsh J (1992) Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest 102:364S–373S

    Article  CAS  Google Scholar 

  14. Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simoons M, Armstrong PW, Topol EJ, Califf RM (1997) Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) I investigators. Circulation 95:2508–2516

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Murat Mert Atmaca.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atmaca, M.M., Simsek, U.B., Midi, I. et al. Diffuse alveolar hemorrhage following intravenous thrombolytic treatment in acute ischemic stroke: a case series. Neurol Sci 41, 233–237 (2020). https://doi.org/10.1007/s10072-019-03997-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-03997-y

Keywords

Navigation